FDA Drafts Guidance on Quality Management for Device Submissions
Published Date: 11/17/2025
Notice
Summary
The FDA is sharing a draft guide to help medical device makers and staff understand new rules about Quality Management Systems starting February 2, 2026. These changes align U.S. rules with global standards, making it easier to prepare and share quality info in device marketing submissions. If you’re in the medical device world, get ready to update your paperwork and share your thoughts by January 16, 2026!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Medical device QMS info required in submissions
If you make medical devices, the QMS (quality management system) rules were amended effective February 2, 2026, to incorporate ISO 13485:2016. The FDA’s draft guidance explains what QMS information must be prepared, maintained, and included in certain marketing submissions so FDA can determine compliance with the new QMS regulation.
Draft guidance adds no new PRA collections
The draft guidance says it contains no new collection of information under the Paperwork Reduction Act. It refers to previously approved FDA collections, including 21 CFR part 820 (CGMP; Quality System) with OMB control number 0910-0073 and other listed OMB approvals.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in